ReviewBioMed research international2018
Review in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.
- The prevalence of antibiotic-resistant Clostridium species in Iran: a meta-analysis.Pathogens and global health · 2019Pooled it
- Comparison of Phenotypic and Genotypic Antimicrobial Resistances in BovineAntibiotics (Basel, Switzerland) · 2026Article
- Diagnostic challenges and treatment approaches forFrontiers in microbiology · 2026Review
- Lipidomics, Microbiota, and IntestinalInternational journal of molecular sciences · 2025Review
- Article
- Case report of clostridium difficile infection after rectal resection with ileostomy.World journal of surgical oncology · 2025Article
- Knowledge Assessment of Hospital Nursing Staff in Saudi Arabia RegardingNursing reports (Pavia, Italy) · 2025Article
- Clinical characteristics and risk factors ofFrontiers in pediatrics · 2025Article
- Comparative genomics of zoonotic pathogen3 Biotech · 2024Article
- A New Convenient Method to Assess Antibiotic Resistance and Antimicrobial Efficacy against PathogenicAntibiotics (Basel, Switzerland) · 2024Article
- Genomic study of EuropeanMicrobial genomics · 2024Article
- Current and Ongoing Developments in TargetingMicroorganisms · 2024Review
- Toxin genotypes, antibiotic resistance and their correlations in Clostridioides difficile isolated from hospitals in Xi'an, China.BMC microbiology · 2024Article
- Pathogenicity and virulence ofVirulence · 2023Review
- Vancomycin vs metronidazole use for the treatment ofHeliyon · 2023Article
- Article
- Clostridioides (Clostridium) difficile: A silent nosocomial pathogen.Saudi medical journal · 2023Review
- A local-scale One Health genomic surveillance ofMicrobial genomics · 2023Article
- Antimicrobial Activity of Tannic AcidMicrobiology spectrum · 2023Article
- c-di-AMP signaling is required for bile salt resistance, osmotolerance, and long-term host colonization byScience signaling · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.